Apitoria Pharma Private Limited
Hyderabad, India
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (3)
○ EMA GMP
○ MHRA GMP
Quick Facts: Apitoria Pharma Private Limited
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Hyderabad, India
- Modalities
- Small Molecule API, HPAPI, Antibiotics API, CNS/CVS API, Oncology API, Antidiabetic API, Complex Molecules API
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Apitoria Pharma Private Limited
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSmall Molecule API, HPAPI, Antibiotics API, CNS/CVS API, Oncology API, Antidiabetic API, Complex Molecules API
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (7 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press3 articles
Broad modality coverage (7 modalities)
Recent News 3 articles
Cohance Lifesciences appoints Ravinath Shetty as Platform COO - Medical Dialogues
Ravinath Shetty Appointed as Platform COO at Cohance Lifesciences - hrtoday.in
Dr. Sanjay Chaturvedi Appointed Chief Executive Officer at Matrix Pharmacorp - Global HR News & Updates - hrtoday.in
Frequently Asked Questions About Apitoria Pharma Private Limited
What is Apitoria Pharma Private Limited's CDMO Signal Score?
Apitoria Pharma Private Limited has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Apitoria Pharma Private Limited for a manufacturing program?
Use the free AI matchmaker to compare Apitoria Pharma Private Limited against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Sai Life Sciences
Hyderabad, India
Small Molecule API, Complex Small Molecules, HPAPI, ADC, Peptides, Oligonucleotides, Lipids / LNP, Intermediates, Drug Discovery (CRO)
Aarti Pharmalabs Limited
Mumbai, India
Small Molecule API, Steroid / Corticosteroid API, HPAPI, Anti-cancer / Cytotoxic API, Xanthine Derivatives, NCE Drug Substance
Laurus Labs
Hyderabad, India
Small Molecule API, Finished Dosage Form (FDF), CDMO (small molecule), Biologics / Large Molecule, Microbial Fermentation, Peptide API, Cell & Gene Therapy (early-stage investment), Anti-retroviral API, Oncology API, ADC (emerging)
Anthem Biosciences
Bengaluru, India
Small Molecule API, Biologics, Peptide API, Oligonucleotide, ADC, Fermentation (Microbial), HPAPI, Biosimilars, Drug Discovery / Medicinal Chemistry
Fermion (Orion Group)
Espoo, Finland
Small Molecule API, HPAPI, Semi-solid drug product (creams, gels, ointments), Hormonal products